Creating a quick test to detect asthma-triggering allergies
Development of a highly sensitive and specific POCT testing asthma triggering allergic IgE
This study is working on a new, easy-to-use test that helps asthma patients quickly find out their allergy levels to common environmental triggers, especially focusing on helping those in minority groups who face more challenges with asthma.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Allerdia INC NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10922887 on NIH RePORTER |
What this research studies
This research aims to develop a new Point-Of-Care Test that can quickly and accurately identify allergic IgE levels related to environmental allergens in asthma patients. The test is designed to be convenient and cost-effective, addressing the significant health disparities faced by minority groups who are disproportionately affected by asthma. By improving the accuracy of allergy detection, the research seeks to enhance patient care and promote healthier living. The methodology involves innovative testing techniques that aim to reduce false positives commonly seen in current IgE tests.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from minority groups, particularly Black, Hispanic, American Indian, Native Alaskan, and Asian populations, who suffer from allergic asthma.
Not a fit: Patients who do not have allergic asthma or those who are not part of the targeted minority groups may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with a reliable and rapid method to identify asthma triggers, leading to better management of their condition.
How similar studies have performed: While the approach of developing a rapid point-of-care test for allergic IgE detection is innovative, similar methodologies have shown promise in other areas of allergy testing.
Where this research is happening
Los Angeles, United States
- Allerdia INC — Los Angeles, United States (Active)
Researchers
- Principal investigator: Zhang, Ke — Allerdia INC
- Study coordinator: Zhang, Ke
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.